216 related articles for article (PubMed ID: 35272876)
41. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
42. Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer.
Matsuo K; Khetan VU; Brunette LL; Jooya ND; Klar M; Wright JD; Roman LD
Gynecol Oncol; 2022 May; 165(2):264-269. PubMed ID: 35232589
[TBL] [Abstract][Full Text] [Related]
43. The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer.
Yu R; Matthews BJ; Beavis AL
Curr Treat Options Oncol; 2022 Oct; 23(10):1339-1352. PubMed ID: 35980519
[TBL] [Abstract][Full Text] [Related]
44. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study.
Raimond E; Ballester M; Hudry D; Bendifallah S; Daraï E; Graesslin O; Coutant C
Gynecol Oncol; 2014 Jun; 133(3):506-11. PubMed ID: 24642092
[TBL] [Abstract][Full Text] [Related]
45. Sentinel lymph node intraoperative analysis in endometrial cancer.
Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
[TBL] [Abstract][Full Text] [Related]
46. Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique.
Eriksson AGZ; Mueller JJ
Curr Opin Oncol; 2021 Sep; 33(5):457-463. PubMed ID: 34264897
[TBL] [Abstract][Full Text] [Related]
47. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
48. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
[TBL] [Abstract][Full Text] [Related]
49. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
[TBL] [Abstract][Full Text] [Related]
50. Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
Schiavone MB; Scelzo C; Straight C; Zhou Q; Alektiar KM; Makker V; Soslow RA; Iasonos A; Leitao MM; Abu-Rustum NR
Ann Surg Oncol; 2017 Jul; 24(7):1965-1971. PubMed ID: 28258415
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006).
Altın D; Taşkın S; Ortaç F; Tokgözoğlu N; Vatansever D; Güler AH; Güngör M; Taşçı T; Beşe T; Turan H; Kahramanoğlu İ; Yalçın İ; Çelik Ç; Demirkıran F; Köse F; Arvas M; Ayhan A; Taşkıran Ç
Gynecol Oncol; 2022 Mar; 164(3):492-497. PubMed ID: 35033380
[TBL] [Abstract][Full Text] [Related]
52. Precise lymph node biopsy for endometrial cancer confined to the uterus: Analysis of 43 clinical cases.
Shi XL; Chen S; Guo GD; Yang YL; Tong KM; Cao W; Huang LL; Zhang YR
Taiwan J Obstet Gynecol; 2024 May; 63(3):369-374. PubMed ID: 38802200
[TBL] [Abstract][Full Text] [Related]
53. Success Rates of Sentinel Lymph Node Mapping for Endometrial Cancer in Patients with Body Mass Index < 45 Compared with Body Mass Index ≥ 45.
Fennimore NJ; Fitch K; Kiff J; Nguyen CG; Garg B; Munro EG; Bruegl AS
J Minim Invasive Gynecol; 2023 Sep; 30(9):735-741. PubMed ID: 37142090
[TBL] [Abstract][Full Text] [Related]
54. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
[TBL] [Abstract][Full Text] [Related]
55. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?
Goncalves BT; Dos Reis R; Ribeiro R; Moretti-Marques R; Schamme FK; Oliveira GS; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Pastore CBP; Kumagai LY; Faloppa CC; Mantoan H; Badiglian-Filho L; De Brot L; Andrade CEMC; Baiocchi G
Int J Gynecol Cancer; 2023 Oct; 33(10):1548-1556. PubMed ID: 37699707
[TBL] [Abstract][Full Text] [Related]
56. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
[TBL] [Abstract][Full Text] [Related]
57. Lymphadenectomy in endometrial cancer - achieving more with less?
Gitas G; Freytag D; Allahqoli L; Baum S; Rody A; Maass N; Dinas K; Laganà AS; Moawad G; Sotiriadis A; Alkatout I
Minim Invasive Ther Allied Technol; 2022 Apr; 31(4):531-539. PubMed ID: 33439061
[TBL] [Abstract][Full Text] [Related]
58. [Clinical analysis of 76 cases of sentinel lymph node detection in cervical cancer and endometrial cancer].
Liang SC; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2017 Sep; 52(9):605-611. PubMed ID: 28954449
[No Abstract] [Full Text] [Related]
59. Sentinel node mapping in high-intermediate and high-risk endometrial cancer: Analysis of 5-year oncologic outcomes.
Cuccu I; Raspagliesi F; Malzoni M; Vizza E; Papadia A; Di Donato V; Giannini A; De Iaco P; Perrone AM; Plotti F; Angioli R; Casarin J; Ghezzi F; Cianci S; Vizzielli G; Restaino S; Petrillo M; Sorbi F; Multinu F; Schivardi G; De Vitis LA; Falcone F; Lalli L; Berretta R; Mueller MD; Tozzi R; Chiantera V; Benedetti Panici P; Fanfani F; Scambia G; Bogani G
Eur J Surg Oncol; 2024 Apr; 50(4):108018. PubMed ID: 38428106
[TBL] [Abstract][Full Text] [Related]
60. The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer.
Bjørnholt SM; Sponholtz SE; Mogensen O; Bouchelouche K; Parner ET; Neumann G; Jochumsen KM; Hamid BH; Davidsen MB; Bjørn SF; Dahl K; Jensen PT
Gynecol Oncol; 2023 Apr; 171():121-128. PubMed ID: 36893488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
